Thomas Steffen — SEC Form 4 filings

SEC reporting owner CIK 1646396. 4 Form 4 filings on record with FilingPulse; latest filed 2025-06-09.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-02-23 to 2025-06-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ANAVEX LIFE SCIENCES CORP. (AVXL)Director41 leg · 5,000 sh · $22,6005

Form 4 filings — Thomas Steffen

FiledFormIssuerReported transactionsSource
2025-06-094ANAVEX LIFE SCIENCES CORP. (AVXL)Option exercise (M): 50,000 @ $1.76 · Tax withholding (F): 11,349 @ $7.75 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2025-04-024ANAVEX LIFE SCIENCES CORP. (AVXL)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-05-174ANAVEX LIFE SCIENCES CORP. (AVXL)Purchase (P): 5,000 @ $4.52EDGAR
2024-02-234ANAVEX LIFE SCIENCES CORP. (AVXL)Grant/award (A): 50,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1646396 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →